1-3 of 3
Brian Ung, PharmD
Close
Sort by
Journal Articles

Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma Post Autologous Stem Cell Transplant: A Comparison of Real-World Treatment Outcomes and Costs

Parameswaran Hari, MD MRCP, MS, Brian Ung, PharmD, Safiya Abouzaid, MPH, PharmD, Quanhong Ni, MS, Kejal Parikh, BSPharm, MS, Amit Agarwal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2189.
https://doi.org/10.1182/blood.V130.Suppl_1.2189.2189
Published: 2017
Journal Articles

Real-World Treatment Outcomes in Patients with Newly Diagnosed Multiple Myeloma Treated with Triplet Therapy without Stem Cell Transplant: An Enhanced Electronic Health Records Database

Ajai Chari, MD, Brian Ung, PharmD, Safiya Abouzaid, MPH, PharmD, Quanhong Ni, MS, Kejal Parikh, BSPharm, MS, Amit Agarwal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2190.
https://doi.org/10.1182/blood.V130.Suppl_1.2190.2190
Published: 2017
Journal Articles

Real-World Outcomes for Maintenance Treatment Sequencing after Receiving Lenalidomide, Bortezomib, and Dexamethasone Induction in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Followed By Autologous Stem Cell Transplant (ASCT)

Rafael Fonseca, MD, Kejal Parikh, BSPharm, MS, Brian Ung, PharmD, Quanhong Ni, MS, Safiya Abouzaid, MPH, PharmD, Amit Agarwal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3463.
https://doi.org/10.1182/blood.V130.Suppl_1.3463.3463
Published: 2017